日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa Trial

CD27激动剂抗体通过肿瘤内刺激介导B细胞恶性肿瘤的临床反应:多中心RiVa试验

Buermann, Lara E; Stanton, Louise; Rose-Zerilli, Matthew J J; Thorne, Kerensa; Coleman, Adam; Turaj, Anna H; Caddy, Joshua; Wignall, Christopher; Keyworth, Nicole; Konn, Zoe; McKay, Pamela; Osborne, Wendy; Linton, Kim; Medd, Patrick; Lown, Robert; Davies, Andrew J; Johnson, Peter W M; Al-Shamkhani, Aymen; Cragg, Mark S; Collins, Graham P; Keler, Tibor; Yellin, Michael; Gentles, Andrew J; Griffiths, Gareth; Lim, Sean H

Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial

晚期霍奇金淋巴瘤反应调整治疗试验的长期随访

Luminari, Stefano; Fossa, Alexander; Trotman, Judith; Molin, Daniel; d'Amore, Francesco; Enblad, Gunilla; Berkahn, Leanne; Barrington, Sally F; Radford, John; Federico, Massimo; Kirkwood, Amy A; Johnson, Peter W M

Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential

弥漫性大B细胞淋巴瘤中的非IG::MYC赋予了其不同的基因组构型和MYC转录激活潜能。

Zhang, Chunye; Stelloo, Ellen; Barrans, Sharon; Cucco, Francesco; Jiang, Dan; Tzioni, Maria-Myrsini; Chen, Zi; Li, Yan; Swennenhuis, Joost F; Makker, Jasmine; Rásó-Barnett, Lívia; Liu, Hongxiang; El-Daly, Hesham; Soilleux, Elizabeth; Shah, Nimish; Nagumantry, Sateesh Kumar; Kyaw, Maw; Prahladan, Mahesh Panatt; Tooze, Reuben; Westhead, David R; Feitsma, Harma; Davies, Andrew J; Burton, Catherine; Johnson, Peter W M; Du, Ming-Qing

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up

REMoDL-B研究中,根据分子亚组分析,在弥漫性大B细胞淋巴瘤的R-CHOP方案中加入硼替佐米的疗效存在差异,随访时间为5年。

Davies, Andrew J; Barrans, Sharon; Stanton, Louise; Caddy, Josh; Wilding, Sam; Saunders, Geoff; Mamot, Christoph; Novak, Urban; McMillan, Andrew; Fields, Paul; Collins, Graham P; Stephens, Richard; Cucco, Francesco; Sha, Chulin; van Hoppe, Moniek; Tooze, Reuben; Davies, John R; Griffiths, Gareth; Schuh, Anna; Burton, Catherine; Westhead, David R; Du, Ming-Qing; Johnson, Peter W M

Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL

MHG 和 DZsig 的比较揭示了它们共同的生物学特性,以及在弥漫性大B细胞淋巴瘤 (DLBCL) 中预后较差的核心重叠群体。

Davies, John R; Hilton, Laura K; Jiang, Aixiang; Barrans, Sharon; Burton, Catherine; Johnson, Peter W M; Davies, Andrew J; Du, Ming-Qing; Tooze, Reuben; Cucco, Francesco; Care, Matthew A; Morin, Ryan D; Steidl, Christian; Sha, Chulin; Westhead, David R; Scott, David W

Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trial

在 PHOENIX 3 期试验中,伊布替尼联合 R-CHOP 治疗未经治疗且共表达 BCL2 和 MYC 的弥漫性大 B 细胞淋巴瘤 (DLBCL) 的临床疗效

Johnson, Peter W M; Balasubramanian, Sriram; Hodkinson, Brendan; Shreeve, S Martin; Sun, Steven; Srinivasan, Srimathi; Steele, Andrew J; Vermeulen, Jessica; Sehn, Laurie H; Wilson, Wyndham H

Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic Strategies

肥胖与脂肪组织免疫代谢改变相关,这可能导致乳腺癌治疗耐药:免疫代谢重编程和新型治疗策略

Savva, Constantinos; Copson, Ellen; Johnson, Peter W M; Cutress, Ramsey I; Beers, Stephen A

Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study

英国PROSECO研究:B细胞恶性肿瘤患者接种两剂和三剂疫苗后针对SARS-CoV-2变异株的免疫反应

Lim, Sean H; Stuart, Beth; Joseph-Pietras, Debora; Johnson, Marina; Campbell, Nicola; Kelly, Adam; Jeffrey, Danielle; Turaj, Anna H; Rolfvondenbaumen, Kate; Galloway, Celine; Wynn, Thomas; Coleman, Adam R; Ward, Benjamin; Long, Karen; Coleman, Helen; Mundy, Carina; Bates, Andrew T; Ayres, Diana; Lown, Robert; Falconer, Janlyn; Brake, Oliver; Batchelor, James; Willimott, Victoria; Bowzyk Al-Naeeb, Anna; Robinson, Lisa; O'Callaghan, Ann; Collins, Graham P; Menne, Tobias; Faust, Saul N; Fox, Christopher P; Ahearne, Matthew; Johnson, Peter W M; Davies, Andrew J; Goldblatt, David

Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2 + breast carcinoma

冠状样结构对原发性浸润性HER2阳性乳腺癌患者曲妥珠单抗疗效的预后意义

Birts, Charles N; Savva, Constantinos; Laversin, Stéphanie A; Lefas, Alicia; Krishnan, Jamie; Schapira, Aron; Ashton-Key, Margaret; Crispin, Max; Johnson, Peter W M; Blaydes, Jeremy P; Copson, Ellen; Cutress, Ramsey I; Beers, Stephen A

KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity.

KIR2DS2 表达可识别具有增强抗癌活性的 NK 细胞

Blunt Matthew D, Vallejo Pulido Andres, Fisher Jack G, Graham Lara V, Doyle Amber D P, Fulton Rebecca, Carter Matthew J, Polak Marta, Johnson Peter W M, Cragg Mark S, Forconi Francesco, Khakoo Salim I